Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Hemispherx Biopharma enters agreement to settle pending securities class actions

Hemispherx Biopharma, Inc. today announced that, as result of court mediation proceedings, it has entered into a written agreement in principle with the Court-appointed lead plaintiffs to settle all of the currently pending securities class actions consolidated in the U.S. District Court for the Eastern District of Pennsylvania.

24 Aug 2010

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

Alnylam Pharmaceuticals, Inc.,a leading RNAi therapeutics company, announced today that it will make a total of 16 oral presentations at the American Chemical Society (ACS) Fall 2010 240th National Meeting & Exposition being held in Boston, Mass. from August 22-26, 2010.

24 Aug 2010

3SBio and Isotechnika enter strategic agreement for voclosporin in China

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products and Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, today announced the signing of a development and commercialization agreement for voclosporin.

24 Aug 2010

Harvard Bioscience announces acquisition of Coulbourn Instruments

Harvard Bioscience, Inc., a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, today announced that it has acquired the business of Coulbourn Instruments through a purchase of substantially all of Coulbourn's assets.

From Harvard Bioscience 24 Aug 2010

ArtVentive Medical Group signs development agreement with Medical Murray

ArtVentive Medical Group, Inc. announced the Company has signed a manufacturing, research and development agreement with Medical Murray Inc.. Medical Murray is a leader in medical device and product development including specialty manufacturing services.

24 Aug 2010

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.

24 Aug 2010

SEB opens new state-of-the-art laboratory operation, R&D facility

Cryo-Cell International, Inc., one of the largest and most established leaders in stem cell innovation today announced that S-Evans Biosciences, the Company's exclusive Célle menstrual stem cell technology license partner in China has opened a new state-of-the-art laboratory operation and research & development facility located in a Hi-Tech park designated to become an epicenter for stem cell and genomics R&D; cellular therapies and stem cell cryopreservation services.

23 Aug 2010

FDA approves Alexion's Rhode Island manufacturing facility as commercial supply source for Soliris

Alexion Pharmaceuticals, Inc. today announced that the US Food and Drug Administration (FDA) has approved Alexion's Rhode Island manufacturing facility (ARIMF) in Smithfield, Rhode Island as a second source of commercial supply for Soliris® (eculizumab).

23 Aug 2010

Getinge's vascular graft production unit receives warning letter from FDA

Getinge's production unit in Wayne, New Jersey, US, has received a warning letter from the US FDA (Food and Drug Administration). The warning letter originates from an inspection performed by the authority on the Wayne plant during the spring of 2010. The FDA's observations and remarks relate to the manufacture of vascular grafts

23 Aug 2010

Samplify receives second series of patent for medical imaging applications

Samplify Systems, Inc., a leading provider of signal-compression technology, semiconductors, and solutions, today announced that the Chinese Government has granted the company its second series of technology patents for medical imaging applications. These new patents come on the heels of the first series of patents that were granted earlier this month for wireless base station compression.

23 Aug 2010

HHS Secretary releases review of new federal approach to medical countermeasures

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today released an examination of the federal government's system to produce medications, vaccines, equipment and supplies needed for a health emergency, known as medical countermeasures. The Public Health Emergency Medical Countermeasure Enterprise Review: Transforming the Enterprise to Meet Long Range National Needs reviews the process and makes recommendations for a better approach.

21 Aug 2010

HHS unveils $1.9B strategy to better prepare for biological threats

"Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, [U.S.] federal authorities Thursday announced a $1.9 billion makeover of the system for identifying and manufacturing drugs and vaccines for public-health emergencies," Tribune Company/Seattle Times reports.

21 Aug 2010

HCG Platinum improves formula of hormone diet product

MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.

21 Aug 2010

Feds to revamp bioterrorism and flu plans

Federal officials say they will revamp strategies for dealing with bioterrorism and pandemic flu because efforts to develop medical solutions have lagged, the Los Angeles Times reports. They "announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies." The makeover includes plans to hasten manufacturing time and improve surveillance to detect such threats more quickly.

21 Aug 2010

ActiveCare announces capital raise commitment, balance sheet restructuring

ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.

21 Aug 2010

First Edition: August 20, 2010

Today's headlines include articles on health insurance for college students, new plans to overhaul the government's bioterror and flu preparations, changes in store for health care for the homeless and a look at the new high risk insurance plans.

20 Aug 2010

Bavarian Nordic comments on Obama Administration's revised strategy for medical countermeasures

Bavarian Nordic A/S -- a leading industrial biotechnology company and long-term collaborator with the U.S. Government on the development of vaccines for the protection against biological threats, today commented on the Obama Administration's revised strategy for development, procurement and stockpiling of medical countermeasures.

20 Aug 2010

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Bioniche Life Sciences Inc., a research-based, technology driven Canadian biopharmaceutical company, today provided an update on the clinical development program for its proprietary product for non-muscle-invasive bladder cancer - Urocidin.

20 Aug 2010

Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance

The New York Times: Johnson & Johnson has said it will "revamp its quality controls, creating a single framework for its drug, medical device and consumer health care divisions." The move comes after the drugmaker saw a number of recalls of its medicines, such as Tylenol and Motrin, as well as probes by a congressional committee and the FDA into actions at its McNeil Consumer Healthcare subsidiary.

20 Aug 2010

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery.

20 Aug 2010

Manufacturing News and Research

Further Reading

Hemispherx Biopharma enters agreement to settle pending securities class actions

Alnylam Pharmaceuticals to present results on RNAi therapeutics at ACS National Meeting

3SBio and Isotechnika enter strategic agreement for voclosporin in China

Harvard Bioscience announces acquisition of Coulbourn Instruments

ArtVentive Medical Group signs development agreement with Medical Murray

Pfizer's Prevenar 13-valent pneumococcal conjugate vaccine receives WHO prequalification

SEB opens new state-of-the-art laboratory operation, R&D facility

FDA approves Alexion's Rhode Island manufacturing facility as commercial supply source for Soliris

Getinge's vascular graft production unit receives warning letter from FDA

Samplify receives second series of patent for medical imaging applications

HHS Secretary releases review of new federal approach to medical countermeasures

HHS unveils $1.9B strategy to better prepare for biological threats

HCG Platinum improves formula of hormone diet product

Feds to revamp bioterrorism and flu plans

ActiveCare announces capital raise commitment, balance sheet restructuring

First Edition: August 20, 2010

Bavarian Nordic comments on Obama Administration's revised strategy for medical countermeasures

Bioniche provides update on Urocidin clinical development program for non-muscle-invasive bladder cancer

Quality issue roundup: J & J revamping controls; The odds for orthopedic surgery; Automatic prescription refills and patient compliance

MicroAire acquires Endotine fixation systems for facial aesthetic surgery

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (2nd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy